Squarepoint
BDSX icon

Squarepoint’s Biodesix BDSX Stock Holding History

Squarepoint’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,092
Closed -$88.7K – 4491
2025
Q1 		$88.7K Buy
7,092
+6,416
+949% +$123K ﹤0.01% 4250
2024
Q4 		$20.7K Buy
+676
New +$19.9K ﹤0.01% 4933
2024
Q2 		– Sell
-682
Closed -$19.5K – 4060
2024
Q1 		$19.5K Buy
+682
New +$23.3K ﹤0.01% 3929
2021
Q3 		– Sell
-1,750
Closed -$462K – 2917
2021
Q2 		$462K Sell
1,750
-488
-22% -$153K ﹤0.01% 2190
2021
Q1 		$909K Sell
2,238
-1,868
-45% -$834K 0.01% 1587
2020
Q4 		$1.66M Buy
+4,106
New +$1.28M 0.01% 1037

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Squarepoint's BDSX Position: Q2 2025 in Review

Squarepoint sold out of Biodesix (BDSX) in Q2 2025, closing a stake of 7,092 shares — an estimated $88.7K sold.

Squarepoint first reported a position in BDSX in Q4 2020 and held it in 6 quarters. The position peaked at $1.66M in Q4 2020. 40 funds tracked by Wall St. Rank hold BDSX as of Q2 2025.

  • Squarepoint reported no remaining Biodesix position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 7,092 Biodesix shares in Q2 2025, an estimated $88.7K.
  • Squarepoint first reported a position in Biodesix in Q4 2020 and held it in 6 quarters.
  • Squarepoint's Biodesix position peaked at $1.66M in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.